You are now leaving

Please click 'Continue to external site' if you want to continue.

Georg Büchner

Group Chief Business Officer


  • +20 years of experience in science, business, corporate development and consulting positions within academia and the pharmaceutical business
  • In the past  worked in various Biotechs and had its own consulting firm, with his involvement spanning start-ups, where he led the sale of Haptogen to Wyeth; to private and public biotechs, including  at  Amgen INC., where he was the BD responsible for Italy, Israel, UK, France and Scandinavia
  • Experience encompasses M&A, private and public fund raising, corporate and business strategy, service business and product/technology in/out-licencing from preclinical to market stage
  • Holds an MBA from the Judge Cambridge University (UK), a PhD in Molecular and Developmental Biology from Kings College London

Helsinn's Senior Executive Committee

Riccardo Braglia

Executive Chairman

Konrad Wilson

Group Chief Financial Officer

Dr. Melanie Rolli

Group Chief Executive Officer

Giorgio Calderari

Vice Chairman

Matteo Missaglia

Group General Counsel, Group Chief Legal Officer

Sergio Cantoreggi

Group Chief Scientific Officer, Global Head of R&D

Georg Büchner

Group Chief Business Officer

Roberta Cannella

Group Chief Manufacturing Officer